Some genetic and molecular alterations have been reported in the “normal mucosa” beyond the tumour resection boundaries, with mutation of the p53 gene [10–12] reported in tumour- and premalignant lesion-adjacent mucosa. The gene discussed is TP53; the disease is neoplasm.